The Novel Agent Pilot Award funds collaborative projects between basic scientists and physician-scientists to develop and evaluate anti-cancer biological agents. Research may include small molecule drugs, antibodies, vaccines, CAR-T, and other cell therapies that selectively target tumors. The award excludes IND-guided advanced preclinical studies and requires multi-PI teams with at least one Massey research member.
Eligible applicants are multi-principal investigator teams of full-time VCU faculty members, with at least one Massey research member. Only one active pilot research award per Massey investigator is allowed. IND-guided advanced preclinical studies are excluded.
